Johnson D E, Chalbaud R A, Holoye P Y, Samuels M L
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):433-5.
This study had the limited aim of ascertaining the efficacy of bleomycin in controlling m etastatic renal carcinoma. Fifteen patients received bleomycin intramuscularly and five patients received the drug via continuous infusion. Only two patients had responses, both mixed. We concluded that the therapeutic value of bleomycin in the treatment of advanced renal carcinoma is negligible.
本研究的有限目的是确定博来霉素在控制转移性肾癌方面的疗效。15名患者接受了博来霉素肌肉注射，5名患者接受了持续输注该药。只有两名患者有反应，均为混合反应。我们得出结论，博来霉素在治疗晚期肾癌方面的治疗价值可忽略不计。
